Ingredient or product comparison
GHK-Cu vs Standard Telogen Effluvium Treatments: Comparison
Minoxidil 5% Opens ATP-sensitive potassium channels; increases blood flow Multiple RCTs; FDA-approved 3–4 months Gold standard for both androgenetic alopecia and telogen effluvium—proven efficacy GHK-Cu (topical) Reduces IL-6/TNF-alpha; stimulates VEGF and der
This source-based comparison does not add ratings or recommend a winner.
- Minoxidil 5%
- Opens ATP-sensitive potassium channels; increases blood flow
- Multiple RCTs; FDA-approved
- 3–4 months
- Gold standard for both androgenetic alopecia and telogen effluvium—proven efficacy
- GHK-Cu (topical)
- Reduces IL-6/TNF-alpha; stimulates VEGF and dermal papilla proliferation
- Limited observational studies; no RCTs in telogen effluvium
- 4–6 months
- Promising adjunct; insufficient evidence as monotherapy
- PRP Injections
- Delivers autologous growth factors (PDGF, TGF-beta, VEGF)
- Multiple small RCTs; meta-analysis shows benefit
- 3–6 months (requires 3+ sessions)
- More robust evidence than GHK-Cu; higher cost and invasiveness
- Iron + Vitamin D Correction
- Addresses nutrient deficiencies that prolong telogen phase
- Strong observational evidence; low cost
- 2–4 months (if deficient)
- First-line intervention if labs confirm deficiency—higher impact than any topical
- Low-Level Laser Therapy
- Stimulates mitochondrial activity; reduces oxidative stress
- FDA-cleared; moderate RCT evidence
- 4–6 months (requires daily use)
- Comparable to GHK-Cu in evidence quality; expensive upfront cost